Clinico-pharmacological examination of Postinor (0.75 mg d-norgestrel).
D000293:Adolescent; D000328:Adult; D003281:Contraceptives, Postcoital / Q000494:pharmacology*; D003283:Contraceptives, Postcoital, Synthetic / Q000009:adverse effects / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D009644:Norgestrel / Q000009:adverse effects / Q000494:pharmacology*
D003281:Contraceptives, Postcoital; D003283:Contraceptives, Postcoital, Synthetic; D012739:Gonadal Steroid Hormones; D006065:Gonadotropins, Pituitary; D009644:Norgestrel